Perceived Cognitive Dysfunction in Fibromyalgia Syndrome

REFERENCES

• Raspe H, Baumgartner C, Wolfe F: The prevalence of fibromyalgia in a rural German community: how much difference do different criteria make? Arthritis Rheum 36: S48, 1993.
   Google Scholar
• Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L: The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum 38: 19–28, 1995.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Bradley LA, Clauw DJ, Glass JM, Goldenberg DL: Evaluating and diagnosing fibromyalgia and comorbid psychiatric disorders. J Clin Psychiatry 69: e28, 2008.
   PubMed Web of Science ®Google Scholar
• Rutledge DN, Mouttapa M, Wood PB: Symptom clusters in fibromyalgia: potential utility in patient assessment and treatment evaluation. Nurs Res 58: 359–367, 2009.
   PubMed Web of Science ®Google Scholar
• Glass JM: Review of cognitive dysfunction in fibromyalgia: a convergence on working memory and attentional control impairments. Rheum Dis Clin North Am 35: 299–311, 2009.
   PubMed Web of Science ®Google Scholar
• Katz RS, Heard AR, Mills M, Leavitt F: The prevalence and clinical impact of reported cognitive difficulties (Fibrofog) in patients with rheumatic disease with and without fibromyalgia. J Clin Rheumatol 10: 53–58, 2004.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Crofford LJ, Mease PJ, Burgess SM, Palmer SC, Abetz L, Martin SA: Patient perspectives on the impact of fibromyalgia. Patient Educ Couns 73: 114–120, 2008.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Clauw DJ, Arnold LM, Goldenberg DL, Witter J, Williams DA, Simon LS, Strand CV, Bramson C, Martin S, Wright TM, Littman B, Wernicke JF, Gendreau RM, Crofford LJ: Fibromyalgia syndrome. J Rheumatol 32: 2270–2277, 2005.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Arnold LM, Crofford LJ, Williams DA, Russell IJ, Humphrey L, Abetz L, Martin SA: Identifying the clinical domains of fibromyalgia: contributions from clinician and patient Delphi exercises. Arthritis Rheum 59: 952–960, 2008.
   PubMed Web of Science ®Google Scholar
• Bennett RM, Jones J, Turk DC, Russell IJ, Matallana L: An internet survey of 2,596 people with fibromyalgia. BMC Musculoskelet Disord 8: 27, 2007.
   PubMed Web of Science ®Google Scholar
• Glass JM, Park DC, Minear M, Crofford LJ: Memory beliefs and function in fibromyalgia patients. J.Psychosom Res 58: 263–269, 2005.
   PubMed Web of Science ®Google Scholar
• Dick BD, Verrier MJ, Harker KT, Rashiq S: Disruption of cognitive function in fibromyalgia syndrome. Pain 139 (3): 610–616, 2008.
   Web of Science ®Google Scholar
• Nicholson K, Martelli MF, Zasler ND: Does pain confound interpretation of neuropsychological test results? NeuroRehabilitation 16: 225–230, 2001.
   PubMed Web of Science ®Google Scholar
• Dick BD, Verrier MJ, Harker KT, Rashiq S: Disruption of cognitive function in fibromyalgia syndrome. Pain 139: 610–616, 2008.
   PubMed Web of Science ®Google Scholar
• Barsevick AM: The concept of symptom cluster. Semin Oncol Nurs 23: 89–98, 2007.
   PubMedGoogle Scholar
• Suhr JA: Neuropsychological impairment in fibromyalgia: relation to depression, fatigue, and pain. J Psychosom Res 55: 321–329, 2003.
   PubMed Web of Science ®Google Scholar
• Grace GM, Nielson WR, Hopkins M, Berg MA: Concentration and memory deficits in patients with fibromyalgia syndrome. J Clin Exp Neuropsychol 21: 477–487, 1999.
   PubMed Web of Science ®Google Scholar
• Landro NI, Stiles TC, Sletvold H: Memory functioning in patients with primary fibromyalgia and major depression and healthy controls. J Psychosom Res 42: 297–306, 1997.
   PubMed Web of Science ®Google Scholar
• Sephton SE, Studts JL, Hoover K, Weissbecker I, Lynch G, Ho I, McGuffin S, Salmon P: Biological and psychological factors associated with memory function in fibromyalgia syndrome. Health Psychol 22: 592–597, 2003.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 Criteria for the classification of fibromyalgia. Arthritis Rheum 33: 160–172, 1990.
   PubMed Web of Science ®Google Scholar
• Seidenberg M, Haltiner A, Taylor MA, Hermann BB, Wyler A: Development and validation of a Multiple Ability Self-Report Questionnaire. J Clin Exp Neuropsychol 16: 93–104, 1994.
   PubMed Web of Science ®Google Scholar
• Martin R, Griffith HR, Sawrie S, Knowlton R, Faught E: Determining empirically based self-reported cognitive change: development of reliable change indices and standardized regression-based change norms for the Multiple Abilities Self-Report Questionnaire in an epilepsy sample. Epilepsy Behav 8: 239–245, 2006.
   PubMed Web of Science ®Google Scholar
• Ferguson RJ, McDonald BC, Saykin AJ, Ahles TA: Brain structure and function differences in monozygotic twins: possible effects of breast cancer chemotherapy. J Clin Oncol 25: 3866–3870, 2007.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Clauw DJ, Gendreau RM, Rao SG, Kranzler J, Chen W, Palmer RH: The efficacy and safety of milnacipran for treatment of fibromyalgia. A randomized, double-blind, placebo-controlled trial. J Rheumatol 36: 398–409, 2009.
   PubMed Web of Science ®Google Scholar
• Clauw DJ, Mease P, Palmer RH, Gendreau RM, Wang Y: Milnacipran for the treatment of fibromyalgia in adults: a 15-week, multicenter, randomized, double-blind, placebo-controlled, multiple-dose clinical trial. Clin Ther 30: 1988–2004, 2008.
   Google Scholar
• Piasecki TM, Hufford MR, Solhan M, Trull TJ: Assessing clients in their natural environments with electronic diaries: rationale, benefits, limitations, and barriers. Psychol Assess 19: 25–43, 2007.
   PubMed Web of Science ®Google Scholar
• Williams DA, Gendreau M, Hufford MR, Groner K, Gracely RH, Clauw DJ: Pain assessment in patients with fibromyalgia syndrome: a consideration of methods for clinical trials. Clin J Pain 20: 348–356, 2004.
   PubMed Web of Science ®Google Scholar
• Wolfe F, Clauw DJ, Fitzcharles MA, Goldenberg DL, Katz RS, Mease P, Russell AS, Russell IJ, Winfield JB, Yunus MB: The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res 62: 600–610, 2010.
   PubMed Web of Science ®Google Scholar
• Smets EM, Garssen B, Bonke B, De Haes JC: The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39: 315–325, 1995.
   PubMed Web of Science ®Google Scholar
• Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ: A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum 50: 2974–2984, 2004.
   PubMed Web of Science ®Google Scholar
• Stewart AL, Ware JE: Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Duke University Press, Durham, NC, 1992.
   Google Scholar
• Sadosky A, Dukes E, Evans C: Reliability of a 1-week recall period for the Medical Outcomes Study Sleep Scale (MOS-SS) in patients with fibromyalgia. Health Qual Life Outcomes 7: 12, 2009.
   PubMed Web of Science ®Google Scholar
• Cappelleri JC, Bushmakin AG, McDermott AM, Dukes E, Sadosky A, Petrie CD, Martin S: Measurement properties of the Medical Outcomes Study Sleep Scale in patients with fibromyalgia. Sleep Med 10: 766–770, 2009.
   PubMed Web of Science ®Google Scholar
• Spielberger CD, Reheiser EC: Assessment of emotions: anger, anxiety, depression, and curiosity. Appl Psychol: Health Well-being 1: 271–302, 2009.
   Web of Science ®Google Scholar
• Spielberger CD: STAXI-2: State-Trait Anger Expression Inventory – 2. Professional Manual. Psychological Assessment Resources (PAR), Inc., Odessa, FL, 1999.
   Google Scholar
• Spielberger CD, Gorsuch, RC, Lushene RE, Vagg PR: Manual for the State-Trait Anxiety Inventory (Form Y): (“Self-evaluation questionnaire”). Consulting Psychologists, Palo Alto, CA, 1983.
   Google Scholar
• Williams DA, Schilling S: Advances in the assessment of fibromyalgia. Rheum Dis Clin North Am 35: 339–357, 2009.
   PubMed Web of Science ®Google Scholar
• Mease PJ, Arnold LM, Choy EH, Clauw DJ, Crofford LJ, Glass JM, Martin SA, Morea J, Simon L, Strand CV, Williams DA: Fibromyalgia syndrome module at OMERACT 9: domain construct. J Rheumatol 36: 2318–2329, 2009.
   PubMed Web of Science ®Google Scholar
• Hertzog C, Lineweaver TT, McGuire CL: Beliefs about memory and aging. Social Cognition and Aging. Edited by Hess TM. Academic Press, San Diego, 1999, pp. 43–68.
   Google Scholar
• Park DC, Glass JM, Minear M, Crofford LJ: Cognitive function in fibromyalgia patients. Arthritis Rheum 44: 2125–2133, 2001.
   PubMed Web of Science ®Google Scholar
• Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL: The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 11: R120, 2009.
   PubMed Web of Science ®Google Scholar